Boston Scientific (BSX) | Stock Overview & Key Data
Boston Scientific Performance Comparison
Stock Range
Today's Range
Low: $94.92
High: $97.25
on October 2, 2025
52 Week Range
Low: $80.64
High: $109.50
on October 30, 2024
on September 9, 2025
All-Time High: $109.50 on September 9, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$142.8B
EPS
1.67
P/E Ratio (TTM)
57.40
Forward P/E
34.35
P/B Ratio
6.33
PEG Ratio
0.39
Div. Yield
N/A
ROE
11.55%
Beta
0.657
Debt to Equity
53.09
Financial Highlights
Profitability
Gross Margin
67.65%
Operating Margin
18.63%
Profit Margin
13.55%
Returns and Earnings
Return on Assets (TTM)
5.39%
Return on Equity (TTM)
11.55%
EBITDA
$5.0B
Net Income (TTM)
$2.5B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$12.54
Quarterly Revenue Growth (YoY)
22.80%
Quarterly Earnings Growth (YoY)
146.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific BSX | 142.83B Large-cap | -1.96% | -9.79% | -7.15% | -3.83% | 7.65% | 13.82% | 142.00% | 133.88% |
| Abbott Laboratories ABT | 233.07B Mega-cap | -0.24% | 1.16% | -0.84% | 0.80% | 17.23% | 18.07% | 30.65% | 21.29% |
| Stryker SYK | 139.22B Large-cap | -0.59% | -6.04% | -6.49% | -2.93% | 2.14% | 4.32% | 75.71% | 64.36% |
| Medtronic plc MDT | 121.93B Large-cap | 1.25% | 2.30% | 8.16% | 7.45% | 19.02% | 8.18% | 15.85% | -12.15% |
| Edwards Lifesciences EW | 45.70B Large-cap | 1.83% | -6.26% | -0.48% | 6.38% | 5.59% | 17.04% | -9.00% | -8.64% |
| Dexcom DXCM | 26.16B Large-cap | -2.72% | -10.58% | -20.51% | -2.49% | -15.36% | -2.45% | -34.95% | -31.15% |
Ownership & Short Interest
Insider Ownership
0.19%
Institutional Ownership
93.66%
Shares Short
19M
Short Ratio
2.76
Short % of Shares Outstanding
1.29%
Average 10-Day Volume
12M
Average 90-Day Volume
9M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BSX's 52-week high and low?
- In the last 52 weeks, Boston Scientific reached a high of $109.50 (on September 9, 2025) and a low of $80.64 (on October 30, 2024).
- What is the market cap and P/E ratio for BSX?
- Curious about Boston Scientific's size and valuation? Its market capitalization stands at 142.83B. When it comes to valuation, the P/E ratio (trailing twelve months) is 57.40, and the forward P/E (looking ahead) is 34.35.
- Does BSX pay dividends? If so, what's the yield?
- As for dividends, Boston Scientific isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Boston Scientific's main competitors or similar companies to consider before investing?
When looking at Boston Scientific, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT233.07B Healthcare Medical Devices 18.07% 30.65% Stryker
SYK139.22B Healthcare Medical Devices 4.32% 75.71% Medtronic plc
MDT121.93B Healthcare Medical Devices 8.18% 15.85% Edwards Lifesciences
EW45.70B Healthcare Medical Devices 17.04% -9.00% Dexcom
DXCM26.16B Healthcare Medical Devices -2.45% -34.95% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Boston Scientific Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Boston Scientific's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.55%, the Debt to Equity ratio from the most recent quarter is 53.09, and its Gross Profit Margin stands at 67.65%.
- What is the recent revenue and earnings growth for BSX?
- Looking at Boston Scientific's growth, its revenue over the trailing twelve months (TTM) was $18B. Compared to the same quarter last year (YoY), quarterly revenue grew by 22.80%, and quarterly earnings saw a YoY growth of 146.00%.
- How much of BSX stock is held by insiders and institutions?
- Wondering who owns Boston Scientific stock? Company insiders (like executives and directors) hold about 0.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 93.66%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.